VioQuest Pharmaceuticals, Inc.
VOQP · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | 156.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | 36.2% | 43.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -272.1% | -241.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -337.3% | -270.9% |
| EPS Diluted | -2.33 | -2.08 | -5.82 | -2.35 |
| % Growth | -12% | 64.3% | -147.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |